Treatment of valvular aortic stenosis in children: a 20-year experience in a single institution
|
|
- Maximillian Blaze Peters
- 5 years ago
- Views:
Transcription
1 Interactive CardioVascular and Thoracic Surgery 27 (2018) doi: /icvts/ivy078 Advance Access publication 19 March 2018 ORIGINAL ARTICLE Cite this article as: Kjellberg Olofsson C, Berggren H, Söderberg B, Sunnegårdh J. Treatment of valvular aortic stenosis in children: a 20-year experience in a single institution. Interact CardioVasc Thorac Surg 2018;27: Treatment of valvular aortic stenosis in children: a 20-year experience in a single institution Cecilia Kjellberg Olofsson a,b, *, Håkan Berggren a,björn Söderberg a and Jan Sunnegårdh a a b Department of Cardiology, The Queen Silvia Children s Hospital, Sahlgrenska University Hospital, Institute of Clinical Sciences, Gothenburg University, Gothenburg, Sweden Department of Pediatrics, Sundsvall Hospital, Sundsvall, Sweden * Corresponding author. Department of Pediatrics, Sundsvall Hospital, Sundsvall, Sweden. Tel: ; cecilia.kjellberg.olofsson@lvn.se (C. Kjellberg Olofsson). Received 8 November 2017; received in revised form 31 January 2018; accepted 16 February 2018 Abstract OBJECTIVES: This study presents short- and long-term follow-up after treatment for isolated valvular aortic stenosis in children with surgical valvotomy as the preferred 1st intervention. METHODS: All patients aged 0 18 years treated between 1994 and 2013 at our centre were reviewed regarding the mode of first treatment, mortality, reinterventions and the need for aortic valve replacement. RESULTS: A total of 113 patients were identified in local registries. There were 44 neonates, 31 infants and 38 children. The mean followup period was 11 years (range 2 22 years). No early deaths and only 2 late deaths were reported. Of the 113 patients, 92 patients had open surgical valvotomy as the 1st intervention. Freedom from reintervention was 80%, 69%, 61%, 57% and 56% at 1, 5, 10, 15 and 20 years, respectively. The main indication for reintervention was valvular stenosis. Freedom from aortic valve replacement was 67%. CONCLUSIONS: Surgical valvotomy of aortic stenosis in this long-term follow-up study resulted in no 30-day mortality and <1% late mortality. Reinterventions were common, with 38% of the patients having surgery or catheter treatment of the aortic valve before the age of 18 years. Among the 40 patients aged 18 years or older at follow-up, 45% had had the aortic valve replaced. Our data do not allow comparison of catheter and surgical treatment, but, based on these results, we find no reason to change our current policy of surgical treatment as 1st intervention in patients with isolated valvular aortic stenosis. Keywords: Congenital valvular aortic stenosis Surgical valvotomy Outcome INTRODUCTION Congenital valvular aortic stenosis, especially critical neonatal aortic stenosis, is a complex and lifelong disease. Available treatment methods are associated with both advantages and disadvantages. Intervention in early life aims at preserving the native valve and delaying the need for aortic valve replacement (AVR) which, in growing children, is more frequently associated with suboptimal results [1]. Both surgical valvotomy (SAV) and balloon valvotomy (BAV) are firmly established as initial treatment methods, and there is an ongoing debate about which method is the most beneficial intervention during childhood [2 10]. There are also groups advocating early valve replacement as the best intervention [11], but no randomized series for different treatment strategies exist. Institutional preferences dictate the mode of primary intervention and later reinterventions. Using different treatment methods, outcomes have varied regarding early and late mortality and the need for reinterventions [3, 4, 12 14]. Since 1994, the Queen Silvia Children s Hospital in Gothenburg has been 1 of 2 centres for paediatric heart surgery in Sweden, serving approximately half of the Swedish paediatric population. In this study, we review 20 years of experience at our centre in treating isolated congenital aortic valve stenosis with SAV as the preferred 1st intervention. MATERIALS AND METHODS We reviewed all patients who had primary treatment for isolated valvular aortic stenosis at our institution between January 1994 and December Patients were identified in our local surgical and catheter registries and followed up until 18 years of age. Only patients selected for biventricular repair were included. Data were collected from patient files in our hospital as well as the referring hospitals. Transthoracic echocardiography was used for evaluating anatomy, Doppler-derived gradients, aortic valve regurgitation and left ventricular function. Doppler gradients were derived using the modified Bernoulli equation for the maximal gradient. Mean gradient was calculated from the traced velocity curve. Aortic VC The Author(s) Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.
2 C. Kjellberg Olofsson et al. / Interactive CardioVascular and Thoracic Surgery 411 regurgitation was graded 0 4 based on the colour Doppler jet and retrograde flow in the descending aorta. For assessment of left ventricular function, left ventricular end-diastolic diameter and left ventricular fractional shortening were used. Hypertrophy was defined as z-scores for interventricular septum or left ventricular posterior wall in diastole >2 SD [15, 16]. Treatment criteria were critical neonatal aortic stenosis and Doppler mean gradient or invasive gradient >50 mmhg. If symptoms of chest pain or fatigue, ischaemic electrocardiographic (ECG) changes, pathological blood pressure reaction on bicycle ergometry testing, left ventricular hypertrophy or depressed left ventricular function were present, a lower gradient was accepted as an indication of intervention. Critical aortic stenosis in the neonate was defined as duct-dependent systemic circulation and/or depressed left ventricular function with left ventricular fractional shortening <28% [17]. Only patients with isolated valvular aortic stenosis were included. Patients with additional heart defects requiring interventional or surgical treatment were excluded. Survival was cross-checked against the Swedish Population Registry as of October The preferred treatment option in our institution is SAV, i.e. commissurotomy including thinning of dysplastic leaflets and shaving off noduli when appropriate. Statistical analysis SPSS statistical software was used for data analysis. Categorical variables were reported as absolute numbers and percentages. Continuous variables were expressed as either mean ± standard deviation or median value and range. For all tests, a P-value <0.05 was considered statistically significant. Freedom from reintervention was calculated using the Kaplan Meier method. This study was approved by the Regional Ethics Review Board of Western Sweden (approval no ). RESULTS Figure 1 shows all interventions and status of 113 patients who met the inclusion criteria for biventricular repair. At 1st intervention, 44 patients were neonates (<_30 days old), 31 patients were infants (1-month to 1-year-old) and 38 patients were children (>1 year). Critical aortic stenosis was diagnosed in 28 of the neonates, of whom 10 had symptoms of low cardiac output at presentation. Five neonates with critical aortic stenosis, aortic valve annulus <5 mm and borderline left ventricle assessed as not adequate to sustain systemic circulation were excluded as they underwent univentricular palliation. A 99 patients were diagnosed with hypoplastic left heart syndrome. The median age at diagnosis was 2 days (range 0 days to 13.6 years; girls 28% and boys 72%). The median age at 1st intervention was 2.8 months ( years). No differences were observed between boys and girls regarding gestational age, birth weight or age at diagnosis (Table 1). The only dropouts were 3 patients who emigrated at 3, 13 and 14 years of age (3, 11 and 14 years after 1st intervention). The median follow-up time was 11.2 years (range years) for mortality and 9 years (range 2 18 years) for reinterventions. Echocardiographic and catheter-derived data are presented in Table 2. Assessment of maximal and mean Doppler gradient before and after SAV or BAV showed a significant decrease from 101 ± 27 to 49 ± 19 mmhg (maximal gradient) and from 57 ± 16 to 29 ± 14 mmhg (mean gradient) for the whole group. Doppler gradients showed a decrease in the SAV group from 104 ± 25 to 47 ± 16 mmhg (maximal gradient) and from 58 ± 15 to 28 ± 12 mmhg (mean gradient) and from 89 ± 39 mmhg to 67 ± 27 mmhg (maximal gradient) and from 56 ± 23 mmhg to 39 ± 21 mmhg (mean gradient) in the BAV group (Fig. 2). Regression analysis demonstrated a statistically significant relationship between left ventricular end-diastolic diameter z-score, Doppler mean gradient (r = -0.32, P = 0.004) and maximal gradient (r = -0.28, P = 0.007) and between interventricular septum in diastole z-score, Doppler mean gradient (r = 0.25, P = 0.033) and maximal gradient (r = 0.27, P = 0.015). No significant relationship was observed between left ventricular posterior wall in diastole and either the mean or the maximal Doppler gradient across the aortic ostium. Comparison of the Doppler mean gradient and catheterderived peak-to-peak gradient was possible in 38 cases. A statistically significant correlation was noted between the catheterderived gradient (mean 55 ± 20 mmhg) and the Doppler mean gradient (mean 53 ± 16 mmhg) (r = 0.54, P < 0.000). Of the initial procedures, there were 92 SAVs, 11 BAVs, 4 Ross procedures, 2 closed transapical valve dilatations and 4 prosthetic valve replacements (Table 3). The primary BAVs were carried out mainly between 2000 and 2006, 8 in the neonatal group, including 6 cases classified as critical valvular aortic stenosis. Three patients were older than 1 year at BAV, of whom 2 had complex extracardiac diseases. Two neonates and 2 children had primary Ross procedures. The 2 closed transapical valve dilatations were carried out in the early study period, 1 in a premature baby weighing 1.5 kg and the other in a baby born at term but small for gestational age, weighing 2.2 kg. No 30-day mortality was reported. One late death occurred in a 10-month-old boy with critical aortic stenosis and severe endocardial fibroelastosis of the left ventricle who presented with severe heart failure. He underwent BAV and a repeat BAV, followed by SAV during the first 2 months of life and was later diagnosed with mitral valve stenosis and died due to heart failure and concomitant pulmonary infection. The other late death was a boy with previous BAV at 13 years of age with prior kidney transplantation, developmental delay and finger malformation. He received a mechanical prosthesis 15 years after the initial BAV treatment and had postoperative left ventricular failure followed by an emergency heart transplantation. He succumbed due to graft failure in the postoperative period at 28 years of age. Reintervention, regardless of the type of initial intervention, was required in 48 (43%) patients at a median age of 4.3 years ( years) and a median 1.2 years (1 day to 16.7 years) after the 1st intervention. Freedom from reintervention was 80%, 69%, 61%, 57% and 56% at 1, 5, 10, 15 and 20 years, respectively (Fig. 3). Reintervention of the aortic valve was performed in 43 patients (38% of the whole cohort), including 58% of the neonates. No significant difference in time was observed from the 1st intervention to reintervention in the different age groups. Residual stenosis was the most common reason for the 1st reintervention, and, on that indication, BAV was the method most commonly used (Fig. 4). The method of reintervention was decided on a case-by-case basis (Table 3). No patient had a significant (Grade 3 or 4) aortic regurgitation at discharge after the 1st intervention. Grade 2 aortic regurgitation was seen in 11 cases, 10 of the 93 after SAV and 1 of the 11 after BAV (n.s.). CONGENITAL
3 412 C. Kjellberg Olofsson et al. / Interactive CardioVascular and Thoracic Surgery All pa ents n=113 neonate (neo): 44 infant(inf): 31 children (ch): 38 UVH HTX Death HTX 1st interven on surgery n=102 SAV: 92 (58) CTV: 2 (0) neo: 36 Ross: 4 (4) inf: 31 AVR Mec: 3 (3) ch: 35 AVR Biol: 1 (0) 21 2nd interven on surgery n=25 SAV: 5 (1) Ross:6 (6) 3 AVR Mec: 7(7) inf: 3 AVR Bio: 3 (0) ch: 9 AVR Hom: 4 (1) 3rd Interven on surgery n=16 SAV: 4 (1) Ross: 5 (4) neo: 9 AVR Mec: 3 (3) inf: 4 AVR Bio: 2 (2) ch: 3 AVR Hom: 2 (1) 4th interven on surgery n=5 AVR Mec: 3 (3 ) AVR Bio: 2 (1 ) neo:3 inf:2 Two patients had heart transplantation at the age of 1.5 and 15 years, respectively. One patient, with a well-developed left ventricle and aortic arch of adequate size but almost atretic aortic valve, had SAV but this was converted on the 1st postoperative day to Norwood surgery when the mitral valve showed severe dysplasia and very poor left ventricular function was seen. AVR was performed in 34 (33%) patients (Table 3). Freedom from AVR at 18 years of age was 56%. Three of the 18-year-olds were born with critical aortic stenosis, and they all had AVR before 18 years of age. A follow-up as of 31 December 2016 revealed that an additional 7 patients had had an AVR. Syndromes or birth defects were noted in 8 patients at admission: Alagille syndrome, pyloric stenosis, pes equinovarus, congenital hip dysplasia, vertebral malformation, renal dysfunction, Turner syndrome and hypospadia. Alivewithout 65 interven on 4 n=69 Alivewithout interven on n=24 Alive without 11 reinterven on 1 n=12 Alivewithout reinterven on n=4 1st interven on BAV n= neo: 8 inf: 0 ch: 3 2nd interven on BAV n= inf:3 ch: 4 3rd interven on BAV n= 2 Figure 1: Flow chart of all interventions and status at follow-up of all patients. Numbers within parenthesis indicate patients with no intervention on aortic valve. AVR: aortic valve replacement; BAV: balloon valvotomy; Bio: biological prosthesis; CTV: closed transventricular valvotomy; Hom: homograft; HTX: heart transplant; Mec: mechanical prosthesis; Ross: Ross procedure; SAV: surgical valvotomy; UVH: univentricular heart. inf: 0 ch: 1 Concomitant structural heart disease diagnoses considered insignificant at the initial treatment were mild aortic regurgitation, mildto-moderate mitral regurgitation, insignificant ventricular septal defects or atrial septal defects, persistent ductus arteriosus and left superior vena cava. In 11 neonates with critical aortic stenosis, endocardial fibroelastosis was found in mild-to-moderate form and in 4 neonates a severe endocardial fibroelastosis was found. Valve morphology was established from surgical reports. The valve was described as functionally unicuspid (n = 3), morphologically bicuspid (n = 12), functionally bicuspid (n =68), tricuspid (n = 20) and quadricuspid (n =1). Description of valve morphology was missing in 3 cases who had surgical interventionandin6caseswhohadonlybav.nostatisticallysignificant difference of the time to reintervention was found when testing all combinations of the different valve morphologies against the different age groups and SAV or BAV as the initial treatment.
4 C. Kjellberg Olofsson et al. / Interactive CardioVascular and Thoracic Surgery 413 Table 1: Patient characteristics Total Neonates (<_ 30 days) Infants (1 month to 1 year) Children (1 18 years) P-value Patients Gestational age (weeks), median (range) 40 (30 42) 39 (32 42) 40 (32 42) 40 (30 41) 0.69 Age at diagnosis (days), median (range) 2 (0 4875) 1 (0 20) 3 (0 183) 30 (0 4875) Age at 1st intervention, median (range) 2.8 months (0 6546) days 6.5 (0 26) days 3.6 ( ) months 12.8 ( ) years Gender, male/female 88/25 35/9 24/7 29/ Weight at birth (kg), mean (SD) 3.4 (0.8) 3.5 (4) 3.7 (2) 3.4 (3.3) 0.55 Weight at 1st intervention (kg), mean (SD) 19.4 (24) 3.5 (0.8) 6.5 (1.8) 48.1 (21) Follow-up time (years), mean (SD) 11 (5.8) 10 (5.4) 11 (6.1) 12 (13) 0.25 Kruskal Wallis test was used for difference between subjects. SD: standard deviation. Table 2: DISCUSSION Echocardiographic and catheter-derived data before and after primary intervention The present study includes all patients from a well-defined geographical area treated for significant valvular aortic stenosis.our institution is a tertiary centre for paediatric cardiac surgery, serving half of Sweden. The inflow of patients has been very stable over time since centralization of paediatric cardiac surgery in Sweden 1994, as no private option for such treatment is available [18]. Congenital valvular aortic stenosis is a fatal disease, immediate in newborns with critical aortic stenosis and leading to premature death in cases with a more moderate degree of stenosis. Thus, the aim of the treatment in the former group was life-saving and in the latter group to prevent untimely death. A main finding in the present study was low mortality, with no 30-day mortality and only 2 late deaths. Total (n = 113) Neonates (n = 44) Infants (n = 31) Children (n = 38) P-value LVEDd (z-score) -0.2 (1.9) (2.1) 0.12 (1.6) (1.9) n.s. IVSd (cm) 0.7 (0.3) (n = 79) 0.5 (0.1) (n = 24) 0.6 (0.2) (n = 25) 1.0 (0.3) (n = 30) *** IVSd (z-score) 1.5 (1.3) 1.2 (1.1) 1.7 (1.4) 1.6 (1.2) n.s. LVEDd (cm) 2.9 (1.3) (n = 92) 1.9 (0.5) (n = 33) 2.4 (0.5) (n = 26) 4.3 (0.9) (n = 33) *** LVPWd (cm) 0.7 (0.5) (n = 82) 0.6 (0.7) (n = 25) 0.5 (0.1) (n = 25) 0.9 (0.3) (n = 32) ** LVPWd (z-score) 1.6 (1.4) 1.7 (1.6) 1.7 (1.1) 1.4 (1.59 n.s. LVFS (%) 38 (12) (n = 90) 30 (12) (n = 33) 40 (9.0) (n = 25) 44 (8.3) (n = 32) *** Aortic annulus (cm) 1.2 (0.6) (n = 87) 0.7 (0.1) (n = 34) 0.9 (0.2) (n = 23) 2.0 (0.4) (n = 30) *** Aortic annulus (z-score) 0.09 (1.6) (1.6) 0.01 (1.6) 0.83 (1.2) ** Peak aortic gradient (mmhg) 97 (31) (n = 112) 86 (37) (n = 43) 113 (23) (n = 31) 95 (21) (n = 38) ** Residual peak aortic gradient (mmhg) 45 (22) (n = 110) 50 (24) (n = 43) 37 (12) (n = 31) 47 (25) (n = 36) * Mean aortic gradient (mmhg) 55 (16) (n = 98) 53 (20) (n = 34) 62 (14) (n = 27) 52 (13) (n = 37) * Residual mean aortic gradient (mmhg) 29 (14) (n = 59) 32 (14) (n = 27) 20 (6.1) (n = 13) 30 (15) (n = 19) * Peak aortic jet velocity (m/s) 4.8 (0.8) (n = 112) 4.5 (1.1) (n = 43) 5.3 (0.5) (n = 31) 4.8 (0.6) (n = 38) ** Residual peak aortic jet velocity (m/s) 3.3 (0.8) (n = 110) 3.4 (0.9) (n = 43) 3.0 (0.5) (n = 31) 3.3 (0.9) (n = 36) n.s. Catheter gradient at BAV (mmhg) 63 (33) (n = 11) 65 (36) (n = 8) 57 (29) (n = 3) n.s. Residual catheter gradient after BAV (mmhg) 30 (16) (n = 11) 34 (18) (n = 8) 20 (19) (n = 3) n.s. Values are presented as mean (standard deviation). Kruskal Wallis test was used of difference between subjects. Values in boldface and/or underlined text indicate difference between groups. n indicates number of patients with documented measurement. *P < **P < ***P <_ BAV: balloon valvotomy; IVSd: interventricular septum in end-diastole; LVEDd: left ventricular end-diastolic dimension; LVFS: left ventricular fractional shortening; LVPWd: left ventricular posterior wall end-diastole; n.s.: not significant. In a comprehensive systematic review and meta-analysis of the outcome after treatment of congenital valvular aortic stenosis in 2368 patients by Hill et al. [4], a 30-day mortality of 4% after SAV and 6% after BAV was found. Long-term survival at 10 years after the 1st intervention with SAV or BAV was 90% and 87%, respectively, whereas our study showed a 10-year survival rate after the 1st intervention of 99%. Long-term results after BAV in a Belgian study of 93 patients reported by Soulatges et al. [19] showed a total mortality of 27% in neonates with critical aortic stenosis and 11.8% in the whole cohort with a mean follow-up of 11.7 years. Ewert et al. [7] reported a 30-day mortality of 3%, and in the neonatal group 9%, after BAV in a multicentre study including 1004 patient. Data on long time survival was not presented. In Finland, in a nationwide survey after BAV, Kallio et al. [20] CONGENITAL
5 414 C. Kjellberg Olofsson et al. / Interactive CardioVascular and Thoracic Surgery Figure 2: Transvalvular gradient before and after 1st intervention with SAV or BAV. BAV: balloon valvotomy; SAV: surgical valvotomy. Table 3: Number of primary interventions and reinterventions Procedure Primary intervention Surgical valvotomy 92 8 Balloon valvotomy Closed transventricular dilatation 2 Ross procedure 4 11 Mechanical prosthesis 3 14 Biological prosthesis 1 6 Homograft in the aortic position 5 Univentricular heart surgery 1 Heart transplantation 2 Other a 20 Total Reinterventions a Patient ductus arteriosus, subvalvular aortic stenosis, pacemaker, endocarditis in aortic homograft, mitral valve regurgitation, stenosis in pulmonary homograft, univentricular heart surgery or heart transplantation due to diastolic dysfunction and thrombus in left atrial appendage. reported a mortality of 6.3% before hospital discharge and no late mortality at a median 6.9-years follow-up. Siddiqui et al. [3], in an Australian study, compared outcome after SAV or BAV in neonates and infants. They reported a 3% hospital mortality and 10% late mortality in the whole group with a mean follow-up period of 10 years. Another recently published article by Galoin-Bertail et al. [21] presented follow-up data from France on 83 patients aged <4 months treated with SAV reporting a 6% early mortality and 85% survival at 15 years with a median follow-up of 4.2 years. Figure 3: Freedom from reintervention in years by age group at 1st intervention. A log-rank test was run to determine whether there were differences in the distribution of the different age groups at reintervention. The distributions for the 3 age categories were not statistically significant: v 2 = 0.102, P = Figure 4: Indications for reinterventions. Asterisk indicates patent ductus arteriosus, subvalvular aortic stenosis, pacemaker, endocarditis in aortic homograft, mitral valve regurgitation, stenosis in pulmonary homograft, univentricular heart surgery or heart transplantation due to diastolic dysfunction and thrombus in left atrial appendage. Even though our mortality results compare favourably, mortality rates should be compared with caution, especially for early mortality, as they may reflect differences in patient selection. In the present study, 28 (25%) patients were classified as having a critical aortic stenosis. An additional 5 patients with critical aortic stenosis were considered unsuitable for biventricular repair and were thus excluded. One patient was converted to univentricular palliation on the 1st postoperative day after SAV, and 2 patients eventually had a heart transplantation. Few studies describe the features of borderline cases with critical aortic stenosis chosen for univentricular palliation, which is important when comparing outcome [22 24]. In our data, borderline cases constituted 5% of all patients undergoing univentricular heart surgery due to critical aortic stenosis or hypoplastic left heart syndrome between 1994
6 C. Kjellberg Olofsson et al. / Interactive CardioVascular and Thoracic Surgery 415 and This study includes patients with SAV, BAV or AVR as the initial treatment, with SAV being the preferred intervention. Nonetheless, 11 patients in our cohort had BAV as the initial treatment, in some cases due to a presumed lower risk of the procedure in patients with extracardiac morbidity. The small number of patients who had BAV as the primary treatment precludes a comparison with SAV in the present study. Adequate gradient reduction was achieved both with SAV and BAV, although more radically after SAV. No patient had significant aortic valve regurgitation at discharge. Other groups have described a higher degree of aortic regurgitation both after BAV and SAV, but in our study, we found Grade 2 aortic regurgitation in only 10% of the patients after the 1st treatment and no patient had severe aortic regurgitation (Grade 3 4) [13, 14]. This is consistent with a careful surgical strategy with commissurotomy and trimming of leaflets to relieve stenosis without risking severe regurgitation. Hraska et al. [6] argued that SAV is preferable, as it can actually improve functioning and lifespan of the native valve. In addition, some studies have demonstrated longer freedom from reintervention for SAV than BAV [3, 13]. In the present study, we found even longer freedom from reintervention: 80%, 69%, 61%, 57% and 56% at 1, 5, 10, 15 and 20 years, respectively. However, our finding of 58% reintervention in the neonatal subgroup at a mean age of 11.2 years matches the 10-year freedom from reintervention of 55% found by Siddiqui et al. [3] in a group of neonates and infants aged <1 year whose primary intervention was SAV or BAV. The most common indication for reintervention in our study was residual stenosis or restenosis. As stenosis, and not regurgitation, was the most common indication, a reintervention with BAV was the method most commonly used. This strategy, with SAV or BAV followed by a second BAV if needed, has been shown to delay the need for an AVR [25]. Furthermore, we did not find any association between age at initial intervention and time to the need for reintervention, which is contrary to the findings in studies using BAV as the primary intervention [8, 19, 26] but consistent with studies using SAV as the primary intervention [3, 21]. A major issue in patients with valvular aortic stenosis is the timing of AVR. Freedom from AVR was 67% in the present study but 50% in the subgroup of neonates with critical stenosis (n = 15). The Ross procedure (n = 15) and mechanical prosthesis (n = 14) were equally common but, as expected, the age distribution was different, with younger patients in the Ross group and older patients in the mechanical prosthesis group. Alternative AVR with biological prosthesis or homograft in the aortic position were relatively rare procedures (n = 5). In the present study, 40 patients reached 18 years of age at follow-up, and freedom from AVR in this subgroup was 55%. However, the 3 patients born with critical aortic stenosis all underwent AVR, as had an additional 7 patients in this specific subgroup of 40 patients when followed up again in 2016 (December 31). We do not have sufficient data to compare the need for AVR after SAV and BAV treatment. Freedom from AVR is an important aspect for followup of valvular aortic stenosis. Our finding of 67% freedom from AVR is substantially higher than the 39% freedom from AVR at 15 years after SAV presented by Galoin-Bertail et al. [21] who found a generally higher incidence of reinterventions. It is also slightly higher than the 57% freedom from AVR after BAV treatment reported by Brown et al. [8] but similar to the 70% after SAV treatment reported by Brown et al. [5] in a 20-year followup. In the meta-analysis by Hill et al. [4], freedom from AVR at 10 years was 76% for BAV and 81% for SAV. Treatment criteria for intervention or reintervention in children with non-critical valvular aortic stenosis, such as transvalvular gradients, regurgitation fraction or signs of impaired left ventricular function, is rarely reported or discussed in the literature. Analysis of the preoperative investigation in the present study revealed that 64 of the 137 eligible ECG recordings (47%), from both primary interventions and reinterventions, showed signs of left ventricular hypertrophy and/or ST-segment depression. Bicycle ergometry testing revealed ST-segment depression and/ or pathological blood pressure reaction in 29 of 49 (59%) cases in patients with non-critical valvular stenosis at primary intervention or at reintervention due to stenosis. Strengths and limitations The strength of this study is that it includes all patients treated for valvular aortic stenosis from a specific geographical area, corresponding to half of the Swedish population, as patients are divided between the 2 Swedish centres based on geography rather than on patient preferences or nature of medical condition. We have only included patients with isolated congenital valvular aortic stenosis. Only 3 patients were lost to follow-up, all due to emigration. A weakness is the retrospective design. Also, different inclusion criteria hinder direct comparison between studies. CONCLUSION In conclusion, SAV was performed as the primary intervention for isolated aortic stenosis in this long-term follow-up study, resulting in no 30-day mortality and <1% late mortality. Reinterventions were common, with 38% of the patients having intervention by surgery or catheter treatment of the aortic valve before the age of 18 years. No correlation between the age at 1st intervention and the time to reintervention was found. The main indication of 1st reintervention was stenosis of the valve. Among the patients who had reached the age of 18 years (n = 40) at the end of the study, 45% had the aortic valve replaced. Our data do not allow comparison of catheter and surgical treatment, but based on these results, we find no reason to change our current policy of surgical treatment as the 1st intervention in patients with isolated valvular aortic stenosis. Funding This work was supported by Sahlgrenska University Hospital, Gothenburg, Sweden. Conflict of interest: none declared. REFERENCES [1] Etnel JRG, Elmont LC, Ertekin E, Mokhles MM, Heuvelman HJ, Roos- Hesselink JW et al. Outcome after aortic valve replacement in children: a systematic review and meta-analysis. J Thorac Cardiovasc Surg 2016;151: e3. [2] Rehnström P, Malm T, Jögi P, Fernlund E, Winberg P, Johansson J et al. Outcome of surgical commissurotomy for aortic valve stenosis in early infancy. Ann Thorac Surg 2007;84: CONGENITAL
7 416 C. Kjellberg Olofsson et al. / Interactive CardioVascular and Thoracic Surgery [3] Siddiqui J, Brizard CP, Galati JC, Iyengar AJ, Hutchinson D, Konstantinov IE et al. Surgical valvotomy and repair for neonatal and infant congenital aortic stenosis achieves better results than interventional catheterization. J Am Coll Cardiol 2013;62: [4] Hill GD, Ginde S, Rios R, Frommelt PC, Hill KD. Surgical Valvotomy Versus Balloon Valvuloplasty for Congenital Aortic Valve Stenosis: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2016;5,doi: [5] Brown JW, Ruzmetov M, Vijay P, Rodefeld MD, Turrentine MW. Surgery for aortic stenosis in children: a 40-year experience. Ann Thorac Surg 2003;76: [6] Hraska V, Sinzobahamvya N, Haun C, Photiadis J, Arenz C, Schneider M et al. The long-term outcome of open valvotomy for critical aortic stenosis in neonates. Ann Thorac Surg 2012;94: [7] Ewert P, Bertram H, Breuer J, Dähnert I, Dittrich S, Eicken A et al. Balloon valvuloplasty in the treatment of congenital aortic valve stenosis a retrospective multicenter survey of more than 1000 patients. Int J Cardiol 2011;149: [8] Brown DW, Dipilato AE, Chong EC, Lock JE, McElhinney DB. Aortic valve reinterventions after balloon aortic valvuloplasty for congenital aortic stenosis: intermediate and late follow-up. J Am Coll Cardiol 2010;56: [9] Reich O, Tax P, Marek J, Rázek V, Gilík J, Tomek V et al. Long term results of percutaneous balloon valvoplasty of congenital aortic stenosis: independent predictors of outcome. Heart 2004;90:70 6. [10] Miyamoto T, Sinzobahamvya N, Wetter J, Kallenberg R, Brecher AM, Asfour B et al. Twenty years experience of surgical aortic valvotomy for critical aortic stenosis in early infancy. Eur J Cardiothorac Surg 2006;30: [11] Elder RW, Quaegebeur JM, Bacha EA, Chen JM, Bourlon F, Williams IA. Outcomes of the infant Ross procedure for congenital aortic stenosis followed into adolescence. J Thorac Cardiovasc Surg 2013;145: [12] Prijic SM, Vukomanovic VA, Stajevic MS, Bjelakovic BB, Zdravkovic MD, Sehic IN et al. Balloon dilation and surgical valvotomy comparison in noncritical congenital aortic valve stenosis. Pediatr Cardiol 2015;36: [13] Brown JW, Rodefeld MD, Ruzmetov M, Eltayeb O, Yurdakok O, Turrentine MW. Surgical valvuloplasty versus balloon aortic dilation for congenital aortic stenosis: are evidence-based outcomes relevant? Ann Thorac Surg 2012;94: [14] McCrindle BW, Blackstone EH, Williams WG, Sittiwangkul R, Spray TL, Azakie A et al. Are outcomes of surgical versus transcatheter balloon valvotomy equivalent in neonatal critical aortic stenosis? Circulation 2001; 104(Suppl 1):I [15] Haycock GB, Schwartz GJ, Wisotsky DH. Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults. J Pediatr 1978;93:62 6. [16] Pettersen MD, Du W, Skeens ME, Humes RA. Regression equations for calculation of Z scores of cardiac structures in a large cohort of healthy infants, children, and adolescents: an echocardiographic study. J Am Soc Echocardiogr 2008;21: [17] Freedom RM (ed). The Natural and Modified History of Congenital Heart Disease. Elmsford, NY: Blackwell Pub./Futura; 2004:s140. [18] Lundström NR, Berggren H, Björkhem G, Jögi P, Sunnegårdh J. Centralization of pediatric heart surgery in Sweden. Pediatr Cardiol 2000;21: [19] Soulatges C, Momeni M, Zarrouk N, Moniotte S, Carbonez K, Barrea C et al. Long-term results of balloon valvuloplasty as primary treatment for congenital aortic valve stenosis: a 20-year review. Pediatr Cardiol 2015; 36: [20] Kallio M, Rahkonen O, Mattila I, Pihkala J. Congenital aortic stenosis: treatment outcomes in a nationwide survey. Scand Cardiovasc J 2017;51: [21] Galoin-Bertail C, Capderou A, Belli E, Houyel L. The mid-term outcome of primary open valvotomy for critical aortic stenosis in early infancy a retrospective single center study over 18 years. J Cardiothorac Surg 2016;11:116. [22] Tuo G, Khambadkone S, Tann O, Kostolny M, Derrick G, Tsang V et al. Obstructive left heart disease in neonates with a borderline left ventricle: diagnostic challenges to choosing the best outcome. Pediatr Cardiol 2013;34: [23] Lofland GK, McCrindle BW, Williams WG, Blackstone EH, Tchervenkov CI, Sittiwangkul R et al. Critical aortic stenosis in the neonate: a multiinstitutional study of management, outcomes, and risk factors. J Thorac Cardiovasc Surg 2001;121: [24] McElhinney DB, Lock JE, Keane JF, Moran AM, Colan SD. Left heart growth, function, and reintervention after balloon aortic valvuloplasty for neonatal aortic stenosis. Circulation 2005;111: [25] Petit CJ, Maskatia SA, Justino H, Mattamal RJ, Crystal MA, Ing FF. Repeat balloon aortic valvuloplasty effectively delays surgical intervention in children with recurrent aortic stenosis. Catheter Cardiovasc Interv 2013; 82: [26] Maskatia SA, Ing FF, Justino H, Crystal MA, Mullins CE, Mattamal RJ et al. Twenty-five year experience with balloon aortic valvuloplasty for congenital aortic stenosis. Am J Cardiol 2011;108:
Long-Term Results of Balloon Valvuloplasty as Primary Treatment for Congenital Aortic Valve Stenosis: a 20-Year Review
DOI 10.1007/s00246-015-1134-4 ORIGINAL ARTICLE Long-Term Results of Balloon Valvuloplasty as Primary Treatment for Congenital Aortic Valve Stenosis: a 20-Year Review Camille Soulatges 1 Mona Momeni 2 Nadia
More informationTreatment of congenital aortic valve disease: Neonatal surgical management. Pascal Vouhé - Sick Children Hospital, Paris
Treatment of congenital aortic valve disease: Neonatal surgical management Pascal Vouhé - Sick Children Hospital, Paris Challenges. valvar lesions. associated lesions. status of left ventricle Valvar lesions.
More informationLong-term results of a strategy of aortic valve repair in the paediatric population: Should we avoid cusp extension?
Long-term results of a strategy of aortic valve repair in the paediatric population: Should we avoid cusp extension? Y d Udekem, J Siddiqui, C Seaman, I Konstantinov, J Galati, M Cheung, C Brizard Royal
More informationPediatric Echocardiography Examination Content Outline
Pediatric Echocardiography Examination Content Outline (Outline Summary) # Domain Subdomain Percentage 1 Anatomy and Physiology Normal Anatomy and Physiology 10% 2 Abnormal Pathology and Pathophysiology
More informationBiventricular strategies for neonatal critical aortic stenosis: High mortality associated with early reintervention
Hickey et al Congenital Heart Disease Biventricular strategies for neonatal critical aortic stenosis: High mortality associated with early reintervention Edward J. Hickey, MD, a Christopher A. Caldarone,
More informationExcellence in heart and lung care. Royal Brompton Hospital, Sydney Street, London SW3 6NP
The Surgical Management of the Bicuspid Aortic Valve in Children Professor D.F Shore Royal Brompton & Harefield NHS Trust Excellence in heart and lung care Royal Brompton Hospital, Sydney Street, London
More informationOptimal initial treatment for congenital aortic valve
ORIGINAL RESEARCH Surgical Valvotomy Versus Balloon Valvuloplasty for Congenital Aortic Valve Stenosis: A Systematic Review and Meta-Analysis Garick D. Hill, MD, MS; Salil Ginde, MD; Rodrigo Rios, MD;
More informationSince first successfully performed by Jatene et al, the
Long-Term Predictors of Aortic Root Dilation and Aortic Regurgitation After Arterial Switch Operation Marcy L. Schwartz, MD; Kimberlee Gauvreau, ScD; Pedro del Nido, MD; John E. Mayer, MD; Steven D. Colan,
More informationLEFT VENTRICULAR OUTFLOW OBSTRUCTION WITH A VSD: OPTIONS FOR SURGICAL MANAGEMENT
LEFT VENTRICULAR OUTFLOW OBSTRUCTION WITH A VSD: OPTIONS FOR SURGICAL MANAGEMENT 10-13 March 2017 Ritz Carlton, Riyadh, Saudi Arabia Zohair AlHalees, MD Consultant, Cardiac Surgery Heart Centre LEFT VENTRICULAR
More informationTAVR 2018: TAVR has high clinical efficacy according to baseline patient risk! ii. Con
TAVR 2018: TAVR has high clinical efficacy according to baseline patient risk! ii. Con Dimitrios C. Angouras, MD, FETCS Associate Professor of Cardiac Surgery National and Kapodistrian University of Athens,
More informationSince the Ross procedure was first described in 1967
Ross-Konno Procedure With Mitral Valve Surgery Norihiko Oka, MD, PhD, Osman Al-Radi, MD, Abdullah A. Alghamdi, MD, Siho Kim, MD, and Christopher A. Caldarone, MD Division of Cardiovascular Surgery, The
More informationPresenter Disclosure. Patrick O. Myers, M.D. No Relationships to Disclose
Presenter Disclosure Patrick O. Myers, M.D. No Relationships to Disclose Aortic Valve Repair by Cusp Extension for Rheumatic Aortic Insufficiency in Children Long term Results and Impact of Extension Material
More informationClinical material and methods. Fukui Cardiovascular Center, Fukui, Japan
Mitral Valve Regurgitation after Atrial Septal Defect Repair in Adults Shohei Yoshida, Satoshi Numata, Yasushi Tsutsumi, Osamu Monta, Sachiko Yamazaki, Hiroyuki Seo, Takaaki Samura, Hirokazu Ohashi Fukui
More informationMITRAL STENOSIS. Joanne Cusack
MITRAL STENOSIS Joanne Cusack BSE Breakdown Recognition of rheumatic mitral stenosis Qualitative description of valve and sub-valve calcification and fibrosis Measurement of orifice area by planimetry
More informationMid-term Result of One and One Half Ventricular Repair in a Patient with Pulmonary Atresia and Intact Ventricular Septum
Mid-term Result of One and One Half Ventricular Repair in a Patient with Pulmonary Atresia and Intact Ventricular Septum Kagami MIYAJI, MD, Akira FURUSE, MD, Toshiya OHTSUKA, MD, and Motoaki KAWAUCHI,
More informationIntroduction. Study Design. Background. Operative Procedure-I
Risk Factors for Mortality After the Norwood Procedure Using Right Ventricle to Pulmonary Artery Shunt Ann Thorac Surg 2009;87:178 86 86 Addressor: R1 胡祐寧 2009/3/4 AM7:30 SICU 討論室 Introduction Hypoplastic
More information가천의대길병원소아심장과최덕영 PA C IVS THE EVALUATION AND PRINCIPLES OF TREATMENT STRATEGY
가천의대길병원소아심장과최덕영 PA C IVS THE EVALUATION AND PRINCIPLES OF TREATMENT STRATEGY PA c IVS (not only pulmonary valve disease) Edwards JE. Pathologic Alteration of the right heart. In: Konstam MA, Isner M, eds.
More informationThe Ross Procedure: Outcomes at 20 Years
The Ross Procedure: Outcomes at 20 Years Tirone David Carolyn David Anna Woo Cedric Manlhiot University of Toronto Conflict of Interest None The Ross Procedure 1990 to 2004 212 patients: 66% 34% Mean age:
More informationWhat is the Definition of Small Systemic Ventricle. Hong Ryang Kil, MD Department of Pediatrics, College of Medicine, Chungnam National University
What is the Definition of Small Systemic Ventricle Hong Ryang Kil, MD Department of Pediatrics, College of Medicine, Chungnam National University Contents Introduction Aortic valve stenosis Aortic coarctation
More informationAortic Valve Practice Guidelines: What Has Changed and What You Need to Know
Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know James F. Burke, MD Program Director Cardiovascular Disease Fellowship Lankenau Medical Center Disclosure Dr. Burke has no conflicts
More informationHypoplastic Left Heart Syndrome: Echocardiographic Assessment
Hypoplastic Left Heart Syndrome: Echocardiographic Assessment Craig E Fleishman, MD, FACC, FASE Director, Non-invasive Cardiac Imaging The Hear Center at Arnold Palmer Hospital for Children, Orlando SCAI
More informationSurgical Valvuloplasty Versus Balloon Aortic Dilation for Congenital Aortic Stenosis: Are Evidence-Based Outcomes Relevant?
Surgical Valvuloplasty Versus Balloon Aortic Dilation for Congenital Aortic Stenosis: Are Evidence-Based Outcomes Relevant? John W. Brown, MD, Mark D. Rodefeld, MD, Mark Ruzmetov, MD, PhD, Osama Eltayeb,
More informationCASE REPORT: DOUBLE ORIFICE MITRAL VALVE WITH CLEFT IN ANTERIOR LEAFLET OF DOMINANT VALVE IN AN AFRO-CARIBBEAN
CASE REPORT: DOUBLE ORIFICE MITL VAE WITH CLEFT IN ANTERIOR LEAFLET OF DOMINANT VAE IN AN AFRO-CARIBBEAN Disclosure: No potential conflict of interest. Received: 27.08.13 Accepted: 23.06.14 Citation: EMJ
More informationPatrick O. Myers, MD, 1,2 Pedro J. del Nido, MD, 1 Sitaram M. Emani, MD, 1 Gerald R. Marx, MD, 3 Christopher W. Baird, MD 1
Valve-Sparing Aortic Root Replacement and Remodeling with Complex Aortic Valve Reconstruction in Children and Young Adults with Moderate or Severe Aortic Regurgitation Patrick O. Myers, MD, 1,2 Pedro J.
More informationHISTORY. Question: What category of heart disease is suggested by the fact that a murmur was heard at birth?
HISTORY 23-year-old man. CHIEF COMPLAINT: Decreasing exercise tolerance of several years duration. PRESENT ILLNESS: The patient is the product of an uncomplicated term pregnancy. A heart murmur was discovered
More informationS. Bruce Greenberg, MD FNASCI and President, NASCI Professor of Radiology and Pediatrics University of Arkansas for Medical Sciences
S. Bruce Greenberg, MD FNASCI and President, NASCI Professor of Radiology and Pediatrics University of Arkansas for Medical Sciences No financial disclosures Aorta Congenital aortic stenosis/insufficiency
More informationPROSTHETIC VALVE BOARD REVIEW
PROSTHETIC VALVE BOARD REVIEW The correct answer D This two chamber view shows a porcine mitral prosthesis with the typical appearance of the struts although the leaflets are not well seen. The valve
More informationData Collected: June 17, Reported: June 30, Survey Dates 05/24/ /07/2010
Job Task Analysis for ARDMS Pediatric Echocardiography Data Collected: June 17, 2010 Reported: Analysis Summary For: Pediatric Echocardiography Exam Survey Dates 05/24/2010-06/07/2010 Invited Respondents
More informationAdult Echocardiography Examination Content Outline
Adult Echocardiography Examination Content Outline (Outline Summary) # Domain Subdomain Percentage 1 2 3 4 5 Anatomy and Physiology Pathology Clinical Care and Safety Measurement Techniques, Maneuvers,
More informationPrenatal Predictors of Postnatal Outcome in Pulmonary Atresia with Intact Ventricular Septum: A Multicenter Study
Fetal Heart Society Concept Research Proposal Date: 10/20/15 Main Study Prenatal Predictors of Postnatal Outcome in Pulmonary Atresia with Intact Ventricular Septum: A Multicenter Study Shaji C. Menon,
More informationA Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision
A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision Prof. Pino Fundarò, MD Niguarda Hospital Milan, Italy Introduction
More informationBicuspid aortic root spared during ascending aorta surgery: an update of long-term results
Short Communication Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results Marco Russo, Guglielmo Saitto, Paolo Nardi, Fabio Bertoldo, Carlo Bassano, Antonio Scafuri,
More informationTricuspid and Pulmonic Valve Disease
Chapter 31 Tricuspid and Pulmonic Valve Disease David A. Tate Acquired disease of the right-sided cardiac valves is much less common than disease of the leftsided counterparts, possibly because of the
More informationIndication, Timing, Assessment and Update on TAVI
Indication, Timing, Assessment and Update on TAVI Swedish Heart and Vascular Institute Ming Zhang MD PhD Interventional Cardiology Structure Heart Disease Conflict of Interest None Starr- Edwards Mechanical
More informationInflow Occlusion for Semilunar Valve Stenosis
Inflow Occlusion for Semilunar Valve Stenosis Robert M. Sade, M.D., Fred A. Crawford, M.D., and Arno R. Hohn, M.D ABSTRACT Twenty-nine patients have had valvotomy with inflow occlusion since 1975 at our
More informationPrevious studies from the Congenital Heart Surgeons
CRITICAL AORTIC STENOSIS IN THE NEONATE: A MULTI-INSTITUTIONAL STUDY OF MANAGEMENT, OUTCOMES, AND RISK FACTORS Gary K. Lofland, MD a Brian W. McCrindle, MD b William G. Williams, MD c Eugene H. Blackstone,
More informationImaging Assessment of Aortic Stenosis/Aortic Regurgitation
Imaging Assessment of Aortic Stenosis/Aortic Regurgitation Craig E Fleishman, MD FACC FASE The Heart Center at Arnold Palmer Hospital for Children, Orlando SCAI Fall Fellows Course 2014 Las Vegas Disclosure
More information5.8 Congenital Heart Disease
5.8 Congenital Heart Disease Congenital heart diseases (CHD) refer to structural or functional heart diseases, which are present at birth. Some of these lesions may be discovered later. prevalence of Chd
More informationCritical Aortic Stenosis in Early Infancy: Surgical Treatment for Residual Lesions After Balloon Dilation
Critical Aortic Stenosis in Early Infancy: Surgical Treatment for Residual Lesions After Balloon Dilation Vladimiro L. Vida, MD, Tomaso Bottio, MD, Ornella Milanesi, MD, Elena Reffo, MD, Roberta Biffanti,
More informationCoarctation of the Aorta
Interventional Management of Coarctation of the Aorta Lee Benson MD Professor Pediatrics (Cardiology) Director, Cardiac Diagnostic & Interventional Unit The Hospital for Sick Children Toronto, Canada Outline
More informationAbsent Pulmonary Valve Syndrome
Absent Pulmonary Valve Syndrome Fact sheet on Absent Pulmonary Valve Syndrome In this condition, which has some similarities to Fallot's Tetralogy, there is a VSD with narrowing at the pulmonary valve.
More informationOutcomes after balloon dilation of congenital aortic stenosis in children and adolescents
Cardiol Young 24; 14: 315 321 Greenwich Medical Media Ltd. ISSN 147-9511 Original Article Outcomes after balloon dilation of congenital aortic stenosis in children and adolescents Carlos A. C. Pedra, Roger
More informationEchocardiographic variables associated with mitral regurgitation after aortic valve replacement for aortic valve stenosis
The Egyptian Heart Journal (2013) 65, 135 139 Egyptian Society of Cardiology The Egyptian Heart Journal www.elsevier.com/locate/ehj www.sciencedirect.com ORIGINAL ARTICLE Echocardiographic variables associated
More informationDoes Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement?
Original Article Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Hiroaki Sakamoto, MD, PhD, and Yasunori Watanabe, MD, PhD Background: Recently, some articles
More informationAnatomy & Physiology
1 Anatomy & Physiology Heart is divided into four chambers, two atrias & two ventricles. Atrioventricular valves (tricuspid & mitral) separate the atria from ventricles. they open & close to control flow
More informationEvaluation of Left Ventricular Diastolic Dysfunction by Doppler and 2D Speckle-tracking Imaging in Patients with Primary Pulmonary Hypertension
ESC Congress 2011.No 85975 Evaluation of Left Ventricular Diastolic Dysfunction by Doppler and 2D Speckle-tracking Imaging in Patients with Primary Pulmonary Hypertension Second Department of Internal
More informationAccepted Manuscript. Will the fourth dimension guide us toward the perfect Norwood arch reconstruction? Minoo N. Kavarana, MD, FACS
Accepted Manuscript Will the fourth dimension guide us toward the perfect Norwood arch reconstruction? Minoo N. Kavarana, MD, FACS PII: S0022-5223(19)30714-7 DOI: https://doi.org/10.1016/j.jtcvs.2019.03.040
More informationSurgery for Congenital Heart Disease
Surgery for Congenital Heart Disease Hickey et al Critical left ventricular outflow tract obstruction: The disproportionate impact of biventricular repair in borderline cases Edward J. Hickey, MD, a Christopher
More informationThe management of patients born with multiple left heart
Predictors of Outcome of Biventricular Repair in Infants With Multiple Left Heart Obstructive Lesions Marcy L. Schwartz, MD; Kimberlee Gauvreau, ScD; Tal Geva, MD Background Decisions regarding surgical
More informationAppendix II: ECHOCARDIOGRAPHY ANALYSIS
Appendix II: ECHOCARDIOGRAPHY ANALYSIS Two-Dimensional (2D) imaging was performed using the Vivid 7 Advantage cardiovascular ultrasound system (GE Medical Systems, Milwaukee) with a frame rate of 400 frames
More informationWhen Does 3D Echo Make A Difference?
When Does 3D Echo Make A Difference? Wendy Tsang, MD, SM Assistant Professor, University of Toronto Toronto General Hospital, University Health Network 1 Practical Applications of 3D Echocardiography Recommended
More informationLong-term results (22 years) of the Ross Operation a single institutional experience
Long-term results (22 years) of the Ross Operation a single institutional experience Authors: Costa FDA, Schnorr GM, Veloso M,Calixto A, Colatusso D, Balbi EM, Torres R, Ferreira ADA, Colatusso C Department
More informationDoppler-echocardiographic findings in a patient with persisting right ventricular sinusoids
Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 1990 Doppler-echocardiographic findings in a patient with persisting right
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Acute coronary syndrome(s), anticoagulant therapy in, 706, 707 antiplatelet therapy in, 702 ß-blockers in, 703 cardiac biomarkers in,
More informationPercutaneous Aortic Valvuloplasty: Long-Term Survival
Percutaneous Aortic Valvuloplasty: Long-Term Survival Angioplasty Summit Seoul April 27, 2007 James R. Margolis MD Carmen Paez MD, Kevin Coy MD, Edward Freeman PhD Miami International Cardiology Consultants
More informationValve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal
Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal I have nothing to disclose. Wide Spectrum Stable vs Decompensated NYHA II IV? Ejection
More informationManagement of Difficult Aortic Root, Old and New solutions
Management of Difficult Aortic Root, Old and New solutions Hani K. Najm MD, Msc, FRCSC,, FACC, FESC Chairman, Pediatric and Congenital Heart Surgery Cleveland Clinic Conflict of Interest None Difficult
More informationBalloon Valvuloplasty for Recurrent Aortic Stenosis After Surgical Valvotomy in Childhood: Immediate and Follow-Up Studies
1106 JACC Vol. 13, No. 5 April 1989: 1106-10 Balloon Valvuloplasty for Recurrent Aortic Stenosis After Surgical Valvotomy in Childhood: Immediate and Follow-Up Studies JON N. MELIONES, MD, ROBERT H. BEEKMAN,
More informationHow to Assess and Treat Obstructive Lesions
How to Assess and Treat Obstructive Lesions Erwin Oechslin, MD, FESC, FRCPC, Director, Congenital Cardiac Centre for Adults Peter Munk Cardiac Centre University Health Network/Toronto General Hospital
More informationThe role of intraoperative TOE in congenital cardiac surgery
The role of intraoperative TOE in congenital cardiac surgery Justiaan Swanevelder Dept of Anaesthesia Groote Schuur and Red Cross War Memorial Children s Hospitals University of Cape Town, South Africa
More information42yr Old Male with Severe AR Mild LV dysfunction s/p TOF -AV Replacement(tissue valve) or AoV plasty- Kyung-Hwan Kim
42yr Old Male with Severe AR Mild LV dysfunction s/p TOF -AV Replacement(tissue valve) or AoV plasty- Kyung-Hwan Kim Current Guideline for AR s/p TOF Surgery is reasonable in adults with prior repair of
More informationThe production of murmurs is due to 3 main factors:
Heart murmurs The production of murmurs is due to 3 main factors: high blood flow rate through normal or abnormal orifices forward flow through a narrowed or irregular orifice into a dilated vessel or
More informationWhen should we intervene surgically in pediatric patient with MR?
When should we intervene surgically in pediatric patient with MR? DR.SAUD A. BAHAIDARAH CONSULTANT, PEDIATRIC CARDIOLOGY ASSISTANT PROFESSOR OF PEDIATRICS HEAD OF CARDIOLOGY AND CARDIAC SURGERY UNIT KAUH
More informationUncommon Doppler Echocardiographic Findings of Severe Pulmonic Insufficiency
Uncommon Doppler Echocardiographic Findings of Severe Pulmonic Insufficiency Rahul R. Jhaveri, MD, Muhamed Saric, MD, PhD, FASE, and Itzhak Kronzon, MD, FASE, New York, New York Background: Two-dimensional
More informationTetralogy of Fallot Latest data in risk stratification and replacement of pulmonic valve
Tetralogy of Fallot Latest data in risk stratification and replacement of pulmonic valve Alexandra A Frogoudaki Adult Congenital Heart Clinic Second Cardiology Department ATTIKON University Hospital No
More informationLate secondary TR after left sided heart disease correction: is it predictibale and preventable
Late secondary TR after left sided heart disease correction: is it predictibale and preventable Gilles D. Dreyfus Professor of Cardiothoracic surgery Nath J, et al. JACC 2004 PREDICT Incidence of secondary
More informationDebate in Management of native COA; Balloon Versus Surgery
Debate in Management of native COA; Balloon Versus Surgery Dr. Amira Esmat, El Tantawy, MD Professor of Pediatrics Consultant Pediatric Cardiac Interventionist Faculty of Medicine Cairo University 23/2/2017
More informationIMAGES. in PAEDIATRIC CARDIOLOGY. Abstract
IMAGES in PAEDIATRIC CARDIOLOGY Images Paediatr Cardiol. 2008 Apr-Jun; 10(2): 11 17. PMCID: PMC3232589 Transcatheter closure of symptomatic aortopulmonary window in an infant F Pillekamp, 1 T Hannes, 1
More informationImaging Assessment of the Pulmonary Valve in Stenosis/Atresia and Regurgitation
Imaging Assessment of the Pulmonary Valve in Stenosis/Atresia and Regurgitation Craig E Fleishman, MD FACC FASE The Heart Center at Arnold Palmer Hospital for Children SCAI Fall Fellows Course 2014 Las
More informationTranscatheter Aortic Valve Replacement: Current and Future Devices: How do They Work, Eligibility, Review of Data
Transcatheter Aortic Valve Replacement: Current and Future Devices: How do They Work, Eligibility, Review of Data Echo Florida 2013 Jonathan J. Passeri, M.D. Co-Director, Heart Valve Program Director,
More informationPaediatrica Indonesiana
Paediatrica Indonesiana VOLUME 53 July NUMBER 4 Original Article Transcatheter vs. surgical closure of patent ductus arteriosus: outcomes and cost analysis Mulyadi M Djer, Mochammading, Mardjanis Said
More informationThe Fate of Small-Diameter Homografts in the Pulmonary Position
The Fate of Small-Diameter Homografts in the Pulmonary Position Nicodème Sinzobahamvya, MD, Jutta Wetter, MD, Hedwig C. Blaschczok, MD, Mi-Young Cho, MD, Anne Marie Brecher, MD, and Andreas E. Urban, MD
More informationHybrid Stage I Palliation / Bilateral PAB
Hybrid Stage I Palliation / Bilateral PAB Jeong-Jun Park Dept. of Thoracic & Cardiovascular Surgery Asan Medical Center, University of Ulsan CASE 1 week old neonate with HLHS GA 38 weeks Birth weight 3.0Kg
More informationCase. 15-year-old boy with bicuspid AV Severe AR with moderate AS. Ross vs. AVR (or AVP)
Case 15-year-old boy with bicuspid AV Severe AR with moderate AS Ross vs. AVR (or AVP) AMC case 14-year-old boy with bicuspid AV Severe AS with mild AR Body size Bwt: 55 kg, Ht: 154 cm, BSA: 1.53 m 2 Echocardiography
More informationSurgery for Aortic Stenosis in Children: A 40-Year Experience
CARDIOVASCULAR Surgery for Aortic Stenosis in Children: A 40-Year Experience John W. Brown, MD, Mark Ruzmetov, MD, PhD, Palaniswamy Vijay, PhD, Mark D. Rodefeld, MD, and Mark W. Turrentine, MD Section
More informationLeft Ventricular Outflow Tract Obstruction
Left Ventricular Outflow Tract Obstruction Department of Paediatrics Left Ventricular Outflow Tract Obstruction Subvalvular aortic stenosis Aortic Stenosis Supravalvular aortic stenosis Aortic Coarctation
More informationInterventional procedures guidance Published: 26 July 2017 nice.org.uk/guidance/ipg586
Transcatheter aortic valve implantation for aortic stenosis Interventional procedures guidance Published: 26 July 17 nice.org.uk/guidance/ipg586 Your responsibility This guidance represents the view of
More informationMinimalist Transcatheter Aortic Valve Replacement (MA-TAVR)
Minimalist Transcatheter Aortic Valve Replacement (MA-TAVR) Jensen HA, Condado JF, Devireddy C, Binongo JN, Leshnower BG, Babaliaros V, Sarin EL, Lerakis S, Guyton RA, Stewart JP, Syed AQ, Mavromatis K,
More informationSeptember 26, 2012 Philip Stockwell, MD Lifespan CVI Assistant Professor of Medicine (Clinical)
September 26, 2012 Philip Stockwell, MD Lifespan CVI Assistant Professor of Medicine (Clinical) Advances in cardiac surgery have created a new population of adult patients with repaired congenital heart
More informationPercutaneous Coronary Intervention and Pulmonary Balloon Valvuloplasty in a Patient With Severe Valvular Pulmonary Stenosis
Case Report Percutaneous Coronary Intervention and Pulmonary Balloon Valvuloplasty in a 56-Year-Old Woman With Severe Valvular Pulmonary Stenosis: A Case Report Ata Firouzi 1, MD; Omid Shafe* 1, MD; Farzad
More informationIn 1980, Bex and associates 1 first introduced the initial
Technique of Aortic Translocation for the Management of Transposition of the Great Arteries with a Ventricular Septal Defect and Pulmonary Stenosis Victor O. Morell, MD, and Peter D. Wearden, MD, PhD In
More informationIndex. interventional.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Ablation, of mitral leaflets, 80 Accucinch Annuloplasty system, for mitral regurgitation, 79, 94 95 Accutrak delivery system, for CoreValve
More informationWill we face a big problem with the aortic valve/root after ASO?
Will we face a big problem with the aortic valve/root after ASO? Laurence Iserin Unité médico-chirurgicale de Cardiologie Congénitale Adulte Hôpital Universitaire Européen Georges Pompidou APHP, Université
More informationEchocardiography. Guidelines for Valve and Chamber Quantification. In partnership with
Echocardiography Guidelines for Valve and Chamber Quantification In partnership with Explanatory note & references These guidelines have been developed by the Education Committee of the British Society
More informationCARDIOVASCULAR SURGERY
Volume 107, Number 4 April 1994 The Journal of THORACIC AND CARDIOVASCULAR SURGERY Cardiac and Pulmonary Transplantation Risk factors for graft failure associated with pulmonary hypertension after pediatric
More informationE xtracardiac conduits placed between the right ventricle
1058 INTERVENTIONAL CARDIOLOGY AND SURGERY Implantation of endovascular stents for the obstructive right ventricular outflow tract H Sugiyama, W Williams, L N Benson... See end of article for authors affiliations...
More informationCitation for published version (APA): Luijendijk, P. (2014). Aortic coarctation: late complications and treatment strategies.
UvA-DARE (Digital Academic Repository) Aortic coarctation: late complications and treatment strategies Luijendijk, P. Link to publication Citation for published version (APA): Luijendijk, P. (2014). Aortic
More informationPredictors of Left Ventricular Remodeling after Aortic Valve Replacement in Pediatric Patients with Isolated Aortic Regurgitation
167 Predictors of Left Ventricular Remodeling after Aortic Valve Replacement in Pediatric Patients with Isolated Aortic Regurgitation Sujatha Buddhe, MD,* Wei Du, PhD,* Henry L. Walters III, MD,* Ralph
More informationRisk Analysis of the Long-Term Outcomes of the Surgical Closure of Secundum Atrial Septal Defects
Korean J Thorac Cardiovasc Surg 2017;50:78-85 ISSN: 2233-601X (Print) ISSN: 2093-6516 (Online) CLINICAL RESEARCH https://doi.org/10.5090/kjtcs.2017.50.2.78 Risk Analysis of the Long-Term Outcomes of the
More informationReconstruction of the Aortic Valve and Root A Practical approach Why and when to repair the aortic valve. Diana Aicher. September 16 th - 18 th 2015
Reconstruction of the Aortic Valve and Root A Practical approach Why and when to repair the aortic valve Diana Aicher September 16 th - 18 th 2015 Why repair the aortic valve? Aortic Valve Replacement
More informationFirst Transfemoral Aortic Valve Implantation In Bulgaria - Crossing The Valve With The Device Is Not Always
ISPUB.COM The Internet Journal of Cardiology Volume 9 Number 2 First Transfemoral Aortic Valve Implantation In Bulgaria - Crossing The Valve With The Device Is Not T D, J P. Citation T D, J P.. First Transfemoral
More informationAORTIC COARCTATION. Synonyms: - Coarctation of the aorta
AORTIC COARCTATION Synonyms: - Coarctation of the aorta Definition: Aortic coarctation is a congenital narrowing of the aorta, usually located after the left subclavian artery, near the ductus or the ligamentum
More informationThe production of murmurs is due to 3 main factors:
Heart murmurs The production of murmurs is due to 3 main factors: high blood flow rate through normal or abnormal orifices forward flow through a narrowed or irregular orifice into a dilated vessel or
More informationAccepted Manuscript. The Left atrioventricular valve: The Achilles Heel of incomplete endocardial cushion defects. Meena Nathan, MD, MPH
Accepted Manuscript The Left atrioventricular valve: The Achilles Heel of incomplete endocardial cushion defects Meena Nathan, MD, MPH PII: S0022-5223(18)32898-8 DOI: https://doi.org/10.1016/j.jtcvs.2018.10.120
More informationSurgical Repair of Ventricular Septal Defect; Contemporary Results and Risk Factors for a Complicated Course
Pediatr Cardiol (2017) 38:264 270 DOI 10.1007/s00246-016-1508-2 ORIGINAL ARTICLE Surgical Repair of Ventricular Septal Defect; Contemporary Results and Risk Factors for a Complicated Course Maartje Schipper
More informationThe outlook for patients with hypoplastic left heart syndrome (HLHS) Tricuspid valve repair in hypoplastic left heart syndrome CHD
Ohye et al Surgery for Congenital Heart Disease Tricuspid valve repair in hypoplastic left heart syndrome Richard G. Ohye, MD a Carlen A. Gomez, MD b Caren S. Goldberg, MD, MS b Holly L. Graves, BA a Eric
More informationUptofate Study Summary
CONGENITAL HEART DISEASE Uptofate Study Summary Acyanotic Atrial septal defect Ventricular septal defect Patent foramen ovale Patent ductus arteriosus Aortic coartation Pulmonary stenosis Cyanotic Tetralogy
More informationEchocardiographic changes after aortic valve replacement: Does the failure rate of mitral valve change? Original Article
Echocardiographic changes after aortic valve replacement: Does the failure rate of mitral valve change? Abstract Arezoo Khosravi (1), Hadi Sheykhloo (2), Reza Karbasi-Afshar (1), Amin Saburi (3) Original
More informationPerimembranous VSD: When Do We Ask For A Surgical Closure? LI Xin. Department of Cardiothoracic Surgery Queen Mary Hospital Hong Kong
Perimembranous VSD: When Do We Ask For A Surgical Closure? LI Xin Department of Cardiothoracic Surgery Queen Mary Hospital Hong Kong Classification (by Kirklin) I. Subarterial (10%) Outlet, conal, supracristal,
More informationMitral Valve Disease, When to Intervene
Mitral Valve Disease, When to Intervene Swedish Heart and Vascular Institute Ming Zhang MD PhD Interventional Cardiology Structure Heart Disease Conflict of Interest None Current ACC/AHA guideline Stages
More information